Showing results (151-160 of 182) with videos related to
Sort By:
Pageof 19
Frontiers in Immunology|July 29, 2021
Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized MedicineJules Russick, Pierre-Emmanuel Foy, Nathalie Josseaume, et al.Angiogenesis|January 15, 2014
Targeting VEGFR1 on endothelial progenitors modulates their differentiation potentialClément d'Audigier, Benoit Gautier, Alexis Yon, et al.Lancet (London, England)|August 2, 2015
First clinical use of a bioprosthetic total artificial heart: report of two casesAlain Carpentier, Christian Latrémouille, Bernard Cholley, et al.Thrombosis and Haemostasis|July 21, 2020
Autoregulation of Pulsatile Bioprosthetic Total Artificial Heart is Involved in Endothelial Homeostasis PreservationDavid M Smadja, Richard Chocron, Elisa Rossi, et al.Annals of Intensive Care|July 17, 2021
Platelet activation in critically ill COVID-19 patientsNader Yatim, Jeremy Boussier, Richard Chocron, et al.Journal of Thrombosis and Haemostasis : JTH|October 10, 2025
Prevention of hemorrhage after implantation of mechanical circulatory support with a purified von Willebrand factor concentrate: results of the early terminated randomized controlled trialAntoine Rauch, Guillaume Lebreton, Mouhamed D Moussa, et al.Circulation|February 24, 2025
Aortic Valve Calcification Is Induced by the Loss of ALDH1A1 and Can Be Prevented by Agonists of Retinoic Acid Receptor Alpha: Preclinical Evidence for Drug RepositioningMickael Rosa, Annabelle Dupont, David M Smadja, et al.Archives of Cardiovascular Diseases|March 1, 2023
Platelet activation and coronavirus disease 2019 mortality: Insights from coagulopathy, antiplatelet therapy and inflammationAurélien Philippe, Richard Chocron, Guillaume Bonnet, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|February 10, 2022
Bioprosthetic Total Artificial Heart in Autoregulated Mode Is Biologically Hemocompatible: Insights for Multimers of von Willebrand FactorBastien Poitier, Richard Chocron, Christophe Peronino, et al.Blood|October 16, 2016
PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics studyMaria Bruzelius, Maria Jesus Iglesias, Mun-Gwan Hong, et al.Pageof 19